Article
Role of micronucleus test in predicting breast cancer susceptibility: a systematic review and meta-analysis.
British journal of cancer - 14 Feb 2012
Cardinale F, Bruzzi P, Bolognesi C
Abstract excerpt
BACKGROUND: The cytokinesis-block micronucleus test (MNT), as a marker of chromosomal mutagen sensitivity, was applied in a number of studies enrolling breast cancer (BC) patients and subjects with known or putative genetic predisposition to BC. The large majority of them involve the evaluation of induced micronuclei (MN) frequency in peripheral lymphocytes, after the in vitro challenge with ionising radiations....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
